{"id":"https://openalex.org/W2105145142","doi":"https://doi.org/10.1200/jco.2004.10.045","title":"Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma","display_name":"Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma","alternate_titles":[],"publication_year":2004,"publication_date":"2004-07-14","ids":{"openalex":"https://openalex.org/W2105145142","doi":"https://doi.org/10.1200/jco.2004.10.045","mag":"2105145142","pmid":"https://pubmed.ncbi.nlm.nih.gov/15254058"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.10.045","doi":"https://doi.org/10.1200/jco.2004.10.045","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2004.10.045","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.10.045?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2105145142"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.10.045?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029855695","display_name":"Gheath Alatrash","orcid":"https://orcid.org/0000-0002-7648-4377","observed_orcids":["https://orcid.org/0000-0002-7648-4377"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gheath Alatrash","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","Experimental Therapeutics Program, Department of Hematology and Medical Oncology, Taussig Cancer Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]},{"raw_affiliation_string":"Experimental Therapeutics Program, Department of Hematology and Medical Oncology, Taussig Cancer Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102785664","display_name":"Thomas E. Hutson","orcid":"https://orcid.org/0000-0002-4529-4212","observed_orcids":["https://orcid.org/0000-0002-4529-4212"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas E. Hutson","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000365259","display_name":"Luis M. Molt\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luis Molto","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035497632","display_name":"Amy L. Richmond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy Richmond","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082200198","display_name":"Cheryl Nemec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cheryl Nemec","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111567764","display_name":"Tarek M. Mekhail","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tarek Mekhail","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111957341","display_name":"Paul J. Elson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Elson","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113669772","display_name":"Charles S. Tannenbaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles Tannenbaum","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063621818","display_name":"Thomas E. Olencki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Olencki","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066748171","display_name":"James Harold Finke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James Finke","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112418138","display_name":"Ronald M. Bukowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ronald M. Bukowski","raw_affiliation_strings":["From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Experimental Therapeutics Program, Cleveland Clinic Taussig Cancer Center, and Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.1058,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.92004712,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"22","issue":"14","first_page":"2891","last_page":"2900"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3937999904155731,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3937999904155731,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.2734000086784363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.23160000145435333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9950000047683716},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cytokine-combination-therapy","display_name":"cytokine combination therapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9559999704360962},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8339999914169312},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9100000262260437},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.9710000157356262},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8740000128746033},{"id":"https://openalex.org/keywords/chemokine-expression","display_name":"chemokine expression","score":0.8109999895095825},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9430000185966492},{"id":"https://openalex.org/keywords/mig","display_name":"MIG","score":0.5479999780654907},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.8579999804496765},{"id":"https://openalex.org/keywords/il-5","display_name":"IL-5","score":0.8550000190734863},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.984000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8971343040466309},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6639679670333862},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5572811365127563},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.5496410727500916},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5218538045883179},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5059797167778015},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4920796751976013},{"id":"https://openalex.org/C2908885563","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Aldesleukin","level":4,"score":0.4637361764907837},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4637295603752136},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.4631708264350891},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4621252715587616},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.45645448565483093},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4296156167984009},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.41417789459228516},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.339318186044693},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.3313622772693634},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32024016976356506},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.28968068957328796},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1230679452419281},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.10.045","doi":"https://doi.org/10.1200/jco.2004.10.045","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2004.10.045","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.10.045?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:15254058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15254058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1200/jco.2004.10.045","doi":"https://doi.org/10.1200/jco.2004.10.045","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2004.10.045","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.10.045?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2105145142.pdf","grobid_xml":"https://content.openalex.org/works/W2105145142.grobid-xml"},"referenced_works_count":70,"referenced_works":["https://openalex.org/W125102600","https://openalex.org/W295327518","https://openalex.org/W1485835599","https://openalex.org/W1502100938","https://openalex.org/W1521747187","https://openalex.org/W1550307968","https://openalex.org/W1564659884","https://openalex.org/W1644502582","https://openalex.org/W1843453924","https://openalex.org/W1858230394","https://openalex.org/W1891921601","https://openalex.org/W1894525365","https://openalex.org/W1912635098","https://openalex.org/W1968107774","https://openalex.org/W1970847065","https://openalex.org/W1978683597","https://openalex.org/W1981937032","https://openalex.org/W1987547827","https://openalex.org/W1989904564","https://openalex.org/W1998605540","https://openalex.org/W2002889366","https://openalex.org/W2008362619","https://openalex.org/W2013525973","https://openalex.org/W2016185817","https://openalex.org/W2019426631","https://openalex.org/W2019948813","https://openalex.org/W2021256410","https://openalex.org/W2028942227","https://openalex.org/W2035566433","https://openalex.org/W2041881143","https://openalex.org/W2042383304","https://openalex.org/W2049689068","https://openalex.org/W2067667773","https://openalex.org/W2069204939","https://openalex.org/W2072336922","https://openalex.org/W2083426483","https://openalex.org/W2086129324","https://openalex.org/W2100510996","https://openalex.org/W2101456601","https://openalex.org/W2109506765","https://openalex.org/W2110429401","https://openalex.org/W2115122746","https://openalex.org/W2130462965","https://openalex.org/W2137695731","https://openalex.org/W2138733343","https://openalex.org/W2140114661","https://openalex.org/W2141577422","https://openalex.org/W2143372911","https://openalex.org/W2145110081","https://openalex.org/W2151707711","https://openalex.org/W2155991561","https://openalex.org/W2159133324","https://openalex.org/W2163796754","https://openalex.org/W2165715544","https://openalex.org/W2185228051","https://openalex.org/W2227053780","https://openalex.org/W2245369264","https://openalex.org/W2317554121","https://openalex.org/W2320415041","https://openalex.org/W2331198416","https://openalex.org/W2334694951","https://openalex.org/W2390035097","https://openalex.org/W2397266215","https://openalex.org/W2399474082","https://openalex.org/W2407918827","https://openalex.org/W2417679862","https://openalex.org/W2768600953","https://openalex.org/W4241450260","https://openalex.org/W4250647025","https://openalex.org/W4313333765"],"related_works":["https://openalex.org/W2088639793","https://openalex.org/W1678404557","https://openalex.org/W2163796754","https://openalex.org/W2023774728","https://openalex.org/W2409054790","https://openalex.org/W1978334304","https://openalex.org/W2471245992","https://openalex.org/W1992756775","https://openalex.org/W2405907244","https://openalex.org/W2049237389"],"abstract_inverted_index":{"PURPOSE:":[0],"Interleukin-12":[1],"(IL-12)":[2],"and":[3,17,47,63,111,174,184,187,202,230,242,261,269,279],"interferon":[4,231,280],"alfa-2b":[5],"(IFN-alpha-2b)":[6],"are":[7,257],"pleiotropic":[8],"cytokines":[9],"with":[10,51,86,152,155,200,205],"activity":[11],"in":[12,49,69,133,233,285],"renal":[13],"cell":[14],"carcinoma":[15],"(RCC)":[16],"malignant":[18],"melanoma":[19],"(MM)":[20],"as":[21,271,273],"single":[22],"agents.":[23],"Preclinical":[24],"studies":[25],"suggest":[26],"concurrent":[27,41],"administration":[28,44,239],"may":[29],"have":[30],"synergistic":[31],"antitumor":[32],"effects.":[33],"We":[34],"conducted":[35],"a":[36,191],"phase":[37,254],"I":[38,162],"trial":[39],"of":[40,45,79,89,193,196,224,240,267,276],"subcutaneous":[42],"(SC)":[43],"IL-12":[46,90,241,260],"IFN-alpha-2b":[48,112,243],"patients":[50,83,150,199],"metastatic":[52],"RCC":[53,201],"or":[54],"MM":[55,206],"to":[56,81],"determine":[57],"toxicity,":[58],"maximum-tolerated":[59],"dose,":[60],"preliminary":[61],"efficacy,":[62],"effects":[64],"on":[65,137,220],"chemokine/cytokine":[66],"gene":[67,138],"expression":[68,139,282],"peripheral":[70],"blood":[71],"mononuclear":[72],"cells":[73],"(PBMCs).":[74],"PATIENTS":[75],"AND":[76],"METHODS:":[77],"Cohorts":[78],"three":[80,130,194],"six":[82],"were":[84,140,157],"treated":[85],"escalating":[87],"doses":[88,252],"(dose":[91,113],"I,":[92,114],"100":[93],"ng/kg;":[94,98,102],"dose":[95,99,103,117,121,125,160,248],"II,":[96,118],"300":[97],"III,":[100,122],"500":[101,105,258],"IV,":[104,126],"ng/kg":[106,259],"SC)":[107,129],"given":[108],"twice":[109],"weekly":[110,132],"1.0":[115,119,123,262],"MU/m(2);":[116,120,124],"3.0":[127],"MU/m(2)":[128,263],"times":[131],"4-week":[134],"cycles.":[135],"Effects":[136],"assessed":[141],"by":[142],"reverse":[143],"transcriptase":[144,216],"polymerase":[145,217],"chain":[146,218],"reaction.":[147],"RESULTS:":[148],"Twenty-six":[149],"(19":[151],"RCC,":[153],"seven":[154],"MM)":[156],"accrued":[158],"at":[159,246],"levels":[161,249],"(n":[163,167,171,176],"=":[164,168,172,177],"3),":[165,169],"II":[166,255],"III":[170],"13),":[173],"IV":[175],"7).":[178],"Dose-limiting":[179],"toxicity":[180],"included":[181],"grades":[182],"3":[183],"4":[185],"hepatotoxicity":[186],"neutropenia/leukopenia.":[188],"Patients":[189],"received":[190],"median":[192],"cycles":[195],"treatment.":[197],"Two":[198],"one":[203],"patient":[204],"had":[207],"partial":[208],"responses.":[209],"Median":[210],"survival":[211],"was":[212,283],"13.8":[213],"months.":[214],"Reverse":[215],"reaction":[219],"PBMCs":[221],"revealed":[222],"induction":[223,266,275],"IP-10,":[225],"Mig,":[226,270],"B7.1":[227],"(CD80),":[228],"interleukin-5,":[229,278],"gamma":[232,281],"selected":[234],"patients.":[235],"CONCLUSION:":[236],"Concurrent":[237],"SC":[238],"is":[244],"possible":[245],"the":[247],"utilized.":[250],"Recommended":[251],"for":[253],"trials":[256],"IFN-alpha-2b.":[264],"Consistent":[265],"IP-10":[268],"well":[272],"variable":[274],"B7.1,":[277],"noted":[284],"PBMCs.":[286]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2105145142","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
